TNL Mediagene price target lowered to $14 at Benchmark after reverse split

Benchmark analyst Fawne Jiang adjusted the firm’s price target on TNL Mediagene (TNMG) to $14 from $3.50 and keeps a Speculative Buy rating on the shares, having lowered the price target when adjusted for the reverse share split. Given lagging Media performance and a subdued FY25 outlook, the firm has “prudently” revised its FY26-FY27 estimates downward to reflect slower organic growth and continued uncertainty around M&A, the analyst tells investors.